GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,497,000 | +11.3% | 80,334 | +11.3% | 0.04% | +9.1% |
| Q1 2022 | $3,143,000 | -2.9% | 72,148 | -1.7% | 0.03% | 0.0% |
| Q4 2021 | $3,238,000 | -23.9% | 73,428 | -34.0% | 0.03% | -23.3% |
| Q3 2021 | $4,254,000 | +11.4% | 111,335 | +16.1% | 0.04% | 0.0% |
| Q2 2021 | $3,819,000 | +12.0% | 95,907 | +0.4% | 0.04% | 0.0% |
| Q1 2021 | $3,409,000 | -40.3% | 95,514 | -38.1% | 0.04% | -34.8% |
| Q4 2020 | $5,714,000 | -99.8% | 154,260 | +74.9% | 0.07% | +6.5% |
| Q3 2020 | $3,324,000,000 | – | 88,210 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |